Application of a methylation gene panel by quantitative PCR for lung cancers

Cancer Letters

Volumn 247, Issue 1-2, 2007, Pages 56-71

  Shivapurkar, Narayan ^a,b   Stastny, Victor ^a   Suzuki, Makoto ^c   Wistuba, Ignacio I ^d   Li, Lin ^e   Zheng, Yingye ^e   Feng, Ziding ^e   Hol, Bernard ^f   Prinsen, Clemens ^f   Thunnissen, Frederik B ^f   Gazdar, Adi F ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c CHIBA UNIVERSITY   (Japan)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e Fred Hutchinson Cancer Research Center   (United States)

^f CANISIUS WILHELMINA HOSPITAL   (Netherlands)

Author keywords

Non small cell lung cancer; Real time PCR; Tumor suppressor gene

Indexed keywords

APC PROTEIN; DEATH ASSOCIATED PROTEIN KINASE; PROTEIN P16; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 3; UVOMORULIN;

3 OST 2 GENE; ADVANCED CANCER; APC GENE; APOPTOSIS; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CELL COMMUNICATION; CELL CYCLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DAPK GENE; DCR1 GENE; DCR2 GENE; DIAGNOSTIC VALUE; DNA DETERMINATION; DNA METHYLATION; EARLY DIAGNOSIS; ECAD GENE; FALSE POSITIVE RESULT; FEMALE; GENE; HCAD GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; LABORATORY DIAGNOSIS; LUNG CANCER; LUNG NON SMALL CELL CANCER; MALE; NON INVASIVE MEASUREMENT; P16 GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE ANALYSIS; RASSF1A GENE; SIGNAL TRANSDUCTION; SOCS1 GENE; SOCS3 GENE; SPUTUM ANALYSIS; SURVIVAL RATE; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; COMPUTER SYSTEMS; DNA METHYLATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; SPUTUM; TUMOR MARKERS, BIOLOGICAL;

EID: 33845662751     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2006.03.020     Document Type: Article

References (38)

1. Greenlee R.T., Hill-Harmon M.B., Murray T., and Thun M. Cancer statistics 2001. CA Cancer J. Clin. 51 (2001) 15-36
2. Jemal A., Murray T., Ward E., Samuels A., Tiwari R.C., Ghafoor A., et al. Cancer statistics, 2005. CA Cancer J. Clin. (2005) 10-30
3. Ellis J.R., and Gleeson F.V. Lung cancer screening. Br. J. Radiol. 74 (2001) 478-485
4. Wingo P.A., Ries L.A., Giovino G.A., Miller D.S., Rosenberg H.M., Shopland D.R., et al. Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. J. Natl Cancer Inst. 91 (1999) 675-690
5. Marcus P.M. Lung cancer screening: an update. J. Clin. Oncol. 19 (2001) 83S-86S
6. Palcic B., Garner D.M., Beveridge J., Sun X.R., Doudkine A., MacAulay C., et al. Increase of sensitivity of sputum cytology using high-resolution image cytometry: field study results. Cytometry 50 (2002) 168-176
7. Herman J.G., and Baylin S.B. Promoter-region hypermethylation and gene silencing in human cancer. Curr. Top. Microbiol. Immunol. 249 (2000) 35-54
8. Sidransky D. Emerging molecular markers of cancer. Nat. Rev. Cancer 2 (2002) 210-219
9. Toyooka K.O., Toyooka S., Maitra A., Feng Q., Kiviat N.C., Smith A., et al. Establishment and validation of real-time polymerase chain reaction method for CDH1 promoter methylation. Am. J. Pathol. 161 (2002) 629-634
10. Shivapurkar N., Stastny V., Takahashi T., Suzuki M., Echebiri C., Reddy J., and Gazdar A.F. Novel real-time PCR assay using a universal molecular marker for diagnosis of hematologic cancers. Int. J. Cancer 116 (2005) 656-660
11. Brabender J., Usadel H., Danenberg K.D., Metzger R., Schneider P.M., Lord R.V., et al. Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival. Oncogene 20 (2001) 3528-3532
12. Usadel H., Brabender J., Danenberg K.D., Jeronimo C., Harden S., Engles J., et al. Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer. Cancer Res. 62 (2002) 371-375
13. Harden S.V., Tokumaru Y., Westra W.H., Goodman S., Ahrendt S.A., and Yang S.C. Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients. Clin. Cancer Res. 9 (2003) 1370-1375
14. Topaloglu O., Hoque M.O., Tokumaru Y., Lee J., Ratovitski E., Sidransky D., and Moon C.S. Detection of promoter hypermethylation of multiple genes in the tumor and bronchoalveolar lavage of patients with lung cancer. Clin. Cancer Res. 10 (2004) 2284-2288
15. Bernfield M., Gotte M., Park P.W., Reizes O., Fitzgerald M.L., Lincecum J., and Zako M. Functions of cell surface heparan sulfate proteoglycans. Annu. Rev. Biochem. 68 (1999) 729-777
16. Esko J.D., and Selleck S.B. Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu. Rev. Biochem. 71 (2002) 435-471
17. Vos M.D., Martinez A., Elam C., Dallol A., Taylor B.J., Latif F., and Clark G.J. A role for the RASSF1A tumor suppressor in the regulation of tubulin polymerization and genomic stability. Cancer Res. 64 (2004) 4244-4250
18. Ashkenazi A. Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat. Rev. Cancer 2 (2002) 420-430
19. Ashkenazi A., and Dixit V.M. Apoptosis control by death and decoy receptors. Curr. Opin. Cell Biol. 11 (1999) 255-260
20. Liggett Jr. W.H., and Sidransky D. Role of the p16 tumor suppressor gene in cancer. J. Clin. Oncol. 16 (1998) 1197-1206
21. Esteller M., Sparks A., Toyota M., Sanchez-Cespedes M., Capella G., Peinado M.A., et al. Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res. 60 (2000) 4366-4371
22. Kogel D., Prehn J.H., and Scheidtmann K.H. The DAP kinase family of pro-apoptotic proteins: novel players in the apoptotic game. Bioessays 23 (2001) 352-358
23. Krebs D.L., and Hilton D.J. SOCS: physiological suppressors of cytokine signaling. J. Cell Sci. 16 (2000) 2813-2819
24. Nicholson S.E., De Souza D., Fabri L.J., Corbin J., Willson T.A., Zhang J.G., et al. Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130. Proc. Natl Acad. Sci. USA 97 (2000) 6493-6498
25. Takeichi M. Morphogenetic roles of classic cadherins. Curr. Opin. Cell Biol. 7 (1995) 619-627
26. Miyamoto K., Asada K., Fukutomi T., Okochi E., Yagi Y., Hasegawa T., et al. Methylation-associated silencing of heparan sulfate d-glucosaminyl 3-O-sulfotransferase-2 (3-OST-2) in human breast, colon, lung and pancreatic cancers. Oncogene 22 (2003) 274-280
27. Shivapurkar N., Toyooka S., Toyooka K.O., Reddy J., Miyajima K., Suzuki M., et al. Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types. Int. J. Cancer 109 (2004) 786-792
28. Toyooka S., Toyooka K.O., Miyajima K., Reddy J.L., Toyota M., Sathyanarayana U.G., et al. Epigenetic down-regulation of death-associated protein kinase in lung cancers. Clin. Cancer Res. 9 (2003) 3034-3041
29. Dammann R., Schagdarsurengin U., Strunnikova M., Rastetter M., Seidel C., Liu L., et al. Epigenetic inactivation of the ras-association domain family 1 (RASSF1A) gene and its function in human carcinogenesis. Histol. Histopathol. 18 (2003) 665-677
30. Fodde R. The multiple functions of tumour suppressors: it's all in APC. Nat. Cell Biol. 5 (2003) 190-192
31. He B., You L., Uematsu K., Zang K., Xu Z., Lee A.Y., et al. SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer. Proc. Natl Acad. Sci. USA 100 (2003) 14133-14138
32. He B., You L., Xu Z., Mazieres J., Lee A.Y., and Jablons D.M. Activity of the suppressor of cytokine signaling-3 promoter in human non-small-cell lung cancer. Clin. Lung Cancer 5 (2004) 366-370
33. Shivapurkar N., Takahashi T., Reddy J., Zheng Y., Stastny V., Collins R., et al. Presence of simian virus 40 DNA sequences in human lymphoid and hematopoietic malignancies and their relationship to aberrant promoter methylation of multiple genes. Cancer Res. 64 (2004) 3757-3760
34. Herman J.G., Graff J.R., Myohanen S., Nelkin B.D., and Baylin S.B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl Acad. Sci. USA 93 (1996) 9821-9826
35. Field J.K., and Youngson J.H. The liverpool lung project: a molecular epidemiological study of early lung cancer detection. Eur. Respir. J. 20 (2002) 464-479
36. Reddy J., Shivapurkar N., Takahashi T., Parikh G., Stastny V., Echebiri C., et al. Differential methylation of genes that regulate cytokine signaling in lymphoid and hematopoietic tumors. Oncogene 24 (2005) 732-736
37. Takahashi T., Shivapurkar N., Reddy J., Shigematsu H., Miyajima K., Suzuki M., et al. DNA methylation profiles of lymphoid and hematopoietic malignancies. Clin. Cancer Res. 10 (2004) 2928-2935
38. Pepe M.S. The Statistical Evaluation of Medical Tests for Classification and Prediction (2003), Oxford University Press, New York, USA